Latest Aisling Capital Management LP Stock Portfolio
$476Million | No. of Holdings #13
Aisling Capital Management LP Performance
2026 Q1-1.90%
YTD-1.90%
2025+148.29%
About Aisling Capital Management LP and 13F Hedge Fund Stock Holdings
On 2026-05-05, the fund reported it's updated stock portfolio. In the 13F Holdings report, Aisling Capital Management LP reported an equity portfolio of $476.3 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Aisling Capital Management LP are BBIO, SNDX, GLUE. The fund has invested 79.3% of it's portfolio in BRIDGEBIO PHARMA INC. (BBIO) and 6.5% of portfolio in SYNDAX PHARMACEUTICALS, INC. (SNDX). <br><br> The fund managers got completely rid off CALCIMEDICA, INC. (CALC) stocks. Aisling Capital Management LP opened new stock positions in EUPRAXIA PHARMACEUTICALS INC. (EPRX). The fund showed a lot of confidence in some stocks as they added substantially to BRIDGEBIO ONCOLOGY THERAPEUTICS (BBOT), COMPASS PATHWAYS PLC (CMPS) (CMPS) and MONTE ROSA THERAPEUTICS INC (GLUE) (GLUE).
Aisling Capital Management LP Equity Portfolio Value
Last Reported on: 05 May, 2026
$476Million
as of May 05, 2026Aisling Capital Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Aisling Capital Management LP made a return of -1.9% in the last quarter. In trailing 12 months, it's portfolio return was 110.12%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| eupraxia pharmaceuticals inc. (eprx) | 2,353,000 |
New stocks bought by Aisling Capital Management LP
Additions
| Ticker | % Inc. |
|---|---|
| bridgebio oncology therapeutics (bbot) | 80.3 |
| compass pathways plc (cmps) | 19.52 |
| monte rosa therapeutics inc (glue) | 5.66 |
Additions to existing portfolio by Aisling Capital Management LP
Reductions
None of the existing positions were reduced by Aisling Capital Management LP
Sold off
| Ticker | $ Sold |
|---|---|
| calcimedica, inc. (calc) | -3,434,140 |
Aisling Capital Management LP got rid off the above stocks
Sector Distribution
Aisling Capital Management LP has about 95.1% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 95.1 |
| Others | 4.9 |
Market Cap. Distribution
Aisling Capital Management LP has about 79.4% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- SMALL-CAP
- UNALLOCATED
| Category | % |
|---|---|
| LARGE-CAP | 79.4 |
| SMALL-CAP | 14.2 |
| UNALLOCATED | 4.9 |
Stocks belong to which Index?
About 93.4% of the stocks held by Aisling Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 93.4 |
| Others | 6.6 |
Aisling Capital Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Aisling Capital Management LP
Aisling Capital Management LP has 13 stocks in it's portfolio. About 99.5% of the portfolio is in top 10 stocks. BBIO proved to be the most loss making stock for the portfolio. SNDX was the most profitable stock for Aisling Capital Management LP last quarter.
$476.29MTotal Value
14.00Positions
05 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Aclaris Therapeutics Inc (Acrs) Aisling Capital Management LP's holding in Aclaris Therapeutics Inc (Acrs) over time | 0.34% | 434,455 | $1.63M 0.34% | 0%unchanged 0 percentunchanged | |
 Bridgebio Pharma Inc. (Bbio) Aisling Capital Management LP's holding in Bridgebio Pharma Inc. (Bbio) over time | 79.35% | 5,089,610 | $377.95M 79.35% | 0%unchanged 0 percentunchanged | |
 Biomea Fusion Inc (Bmea) Aisling Capital Management LP's holding in Biomea Fusion Inc (Bmea) over time | 0.66% | 2,048,760 | $3.13M 0.66% | 0%unchanged 0 percentunchanged | |
 CMPS Compass Pathways Plc (Cmps)Compass Pathways Plc (Cmps)CMPS | 1.66% | 1,432,340 | $7.92M 1.66% | 19.52%increased 19.52 percentadded | |
 Monte Rosa Therapeutics Inc (Glue) Aisling Capital Management LP's holding in Monte Rosa Therapeutics Inc (Glue) over time | 5.37% | 1,555,660 | $25.59M 5.37% | 5.66%increased 5.66 percentadded | |
 Marker Therapeutics, Inc. (Mrkr) Aisling Capital Management LP's holding in Marker Therapeutics, Inc. (Mrkr) over time | 0.09% | 325,370 | $423.0K 0.09% | 0%unchanged 0 percentunchanged | |
 Syndax Pharmaceuticals, Inc. (Sndx) Aisling Capital Management LP's holding in Syndax Pharmaceuticals, Inc. (Sndx) over time | 6.46% | 1,316,810 | $30.76M 6.46% | 0%unchanged 0 percentunchanged | |
 Scholar Rock Holding Corporation (Srrk) Aisling Capital Management LP's holding in Scholar Rock Holding Corporation (Srrk) over time | 0.8% | 77,031 | $3.79M 0.8% | 0%unchanged 0 percentunchanged | |
 Urogen Pharma Ltd. (Urgn) Aisling Capital Management LP's holding in Urogen Pharma Ltd. (Urgn) over time | 0.41% | 108,000 | $1.94M 0.41% | 0%unchanged 0 percentunchanged | |
Com Bicara Therapeutics Inc. (Bcax)Bicara Therapeutics Inc. (Bcax) | 2.38% | 568,919 | $11.32M 2.38% | 0%unchanged 0 percentunchanged | |
Com New Bridgebio Oncology Therapeutics (Bbot)Bridgebio Oncology Therapeutics (Bbot) | 1.91% | 1,018,020 | $9.11M 1.91% | 80.3%increased 80.3 percentadded | |
Com Eupraxia Pharmaceuticals Inc. (Eprx)Eupraxia Pharmaceuticals Inc. (Eprx) | 0.49% | 325,000 | $2.35M 0.49% | Newnew position | |
Com Cl A Onkure Therapeutics, Inc. (Okur)Onkure Therapeutics, Inc. (Okur) | 0.08% | 88,607 | $366.8K 0.08% | 0%unchanged 0 percentunchanged | |
Com New Calcimedica, Inc. (Calc)Calcimedica, Inc. (Calc) | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |